Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults
Marco MulaDivision of Neurology, Trinity Hospital, Borgomanero, ItalyAbstract: Epilepsy is one of the most common neurologic disorders, affecting about 50 million people around the world. It is recognized that around 50% of patients with newly diagnosed epilepsy become seizure-free with the first dr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-05-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/profile-of-once-daily-zonisamide-as-monotherapy-for-treatment-of-parti-a13034 |